CF
DGX icon

Corebridge Financial’s Quest Diagnostics DGX Stock Holding History

Corebridge Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,504
Closed -$4.32M – 763
2025
Q1 		$4.32M Sell
25,504
-921
-3% -$151K 0.02% 740
2024
Q4 		$3.99M Sell
26,425
-1,210
-4% -$188K 0.02% 780
2024
Q3 		$4.29M Sell
27,635
-749
-3% -$112K 0.02% 778
2024
Q2 		$3.89M Buy
+28,384
New +$3.89M 0.02% 797

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Corebridge Financial's DGX Position: Q2 2025 in Review

Corebridge Financial sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 25,504 shares — an estimated $4.32M sold.

Corebridge Financial first reported a position in DGX in Q2 2024 and held it in 4 quarters. The position peaked at $4.32M in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Corebridge Financial reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 25,504 Quest Diagnostics shares in Q2 2025, an estimated $4.32M.
  • Corebridge Financial first reported a position in Quest Diagnostics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Quest Diagnostics position peaked at $4.32M in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.